WO2026119216 - ANTIBODY PURIFICATION METHOD
National phase entry is expected:
Publication Number
WO/2026/119216
Publication Date
11.06.2026
International Application No.
PCT/CN2025/139872
International Filing Date
04.12.2025
Title **
[English]
ANTIBODY PURIFICATION METHOD
[French]
PROCÉDÉ DE PURIFICATION D'ANTICORPS
[Chinese]
一种抗体的纯化方法
Applicants **
QILU PHARMACEUTICAL CO., LTD.
Inventors
XING, Tingting
SUN, Bo
AN, Zhenming
YANG, Li
ZHENG, Weigang
WEI, Weikun
JIA, Guodong
CHEN, Junliang
YU, Yue
LV, Zhongcheng
Priority Data
202411774221.4
04.12.2024
CN
202511783917.8
28.11.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1629 | |
| EPO | Filing, Examination, Granting | 11600 | |
| Japan | Filing, Examination, Granting | 2024 | |
| South Korea | Filing, Examination, Granting | 1815 | |
| USA | Filing, Examination, Granting | 4740 |

Total:
21,808
Contact Us
Abstract[English]
Provided is a method for purifying an antibody from a cell culture harvest solution. By means of combining a conventional antibody purification method and octanoic acid or octanoate incubation, the method reduces the content and types of host cell proteins (HCPs), wherein a polysorbate-stabilized antibody composition is obtained by the purification method, the octanoate incubation can further reduce the aggregate content and improve the protein purity, and the process is simple and easy to operate.[French]
L'invention concerne un procédé de purification d'un anticorps à partir d'une solution de récolte de culture cellulaire. La combinaison d'un procédé de purification d'anticorps classique et d'une incubation d'acide octanoïque ou d'octanoate, permet au procédé de réduire la teneur et les types de protéines de cellule hôte (HCP), une composition d'anticorps stabilisée au polysorbate étant obtenue par le procédé de purification, l'incubation d'octanoate pouvant en outre réduire la teneur en agrégat et améliorer la pureté de protéine, et le procédé étant simple et facile à mettre en œuvre.[Chinese]
提供一种从细胞培养收获液中纯化抗体的方法,该方法通过常规抗体纯化方法结合辛酸或辛酸盐孵育,减少宿主细胞蛋白(HCP)含量和种类,通过该纯化方法可获得聚山梨酯稳定的抗体组合物。同时辛酸盐孵育可进一步降低聚体含量,提高蛋白纯度,且工艺简单,易于操作。